earns

Investing.com — Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company. Analysts at Jefferies highlighted the potential of MBX’s lead program, MBX-2109, which is currently in Phase II trials for hypoparathyroidism. They expressed confidence in the company’s…

D.A. Davidson analysts downgraded Microsoft (NASDAQ:) on Monday from a Buy to a Neutral rating, while maintaining a $475 price target. The firm cited intensifying competition in AI as the reason for the revision, noting that competitors have largely caught up with Microsoft’s AI capabilities, “which reduces the justification for…

By Tom Bergin, Lawrence Delevingne and Koh Gui Qing (Reuters) – Donald J. Trump’s golf club in Jupiter, Florida, where multi-million-dollar villas flank the greens of an 18-hole course, reflects the new geography of his family business. Long based in New York, the Trump Organization has gravitated recently to Florida’s…